Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SVT-4A1011 (Servatus Biopharmaceuticals)
- Development stage
- Unknown
- Lead developer
- Servatus Biopharmaceuticals
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
SVT-4A1011 is an investigational live biotherapeutic product (LBP) developed by Servatus Biopharmaceuticals for the treatment of insomnia and sleep disorders. It is composed of a consortium of specific live microbial strains that function as a microbiome modulator and bacteria replacement therapy. Unlike traditional sedative-hypnotics that target central nervous system receptors like GABA or orexin, SVT-4A1011 is designed to improve sleep outcomes by influencing the gut-brain axis. The product is administered orally and has been evaluated in a Phase I/II randomized, double-blind, placebo-controlled clinical trial to assess its safety, tolerability, and efficacy in adults with clinically diagnosed insomnia.
Beyond the preview
Go deeper on SVT-4A1011 (Servatus Biopharmaceuticals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SVT-4A1011 (Servatus Biopharmaceuticals).